3886
A. Khalaf et al. / Tetrahedron 67 (2011) 3881e3886
Compound 17a: white crystals (42 mg, 72% yield). Mp: 122e124 ꢂC.
was filtered on silica gel, and concentrated in vacuo. The twoisomers
19a and 19b were obtained as a 2/1 mixture by NMR analysis. The,
inseparable mixture, of 19a and 19b was isolated as yellow oil by
chromatography on silica gel (115 mg, 97% yield). The analysis of the
spectral data could be done on this purified reaction mixture. 19a:
Rf¼0.49 (Et2O/pentane, 20/80). 1H NMR (CDCl3, 400 MHz)
d, ppm:
2.31 (s, 3H); 2.32 (s, 3H); 3.74 (s, 3H); 6.19 (d, 1H, J¼15.8 Hz);
7.30e7.33 (m, 2H); 7.38 (s, 1H); 7.39 (s, 1H); 7.51e7.54 (m, 2H); 7.83
(dt,1H, JHH¼15.8 Hz, JHF¼1.9 Hz). 13C NMR (CDCl3,100 MHz)
d, ppm:
1
19.5; 19.8; 51.6; 119.5; 120.6 (t, JCF¼242.4 Hz); 124.6 (t,
Rf¼0.42 (Et2O/pentane, 10/90). 1H NMR (CDCl3, 400 MHz)
d, ppm:
3
3
5JCF¼2.3 Hz); 127.8 (t, JCF¼5.1 Hz); 127.9 (t, JCF¼7.9 Hz); 129.1;
1.26 (t, 3H, J¼7.1 Hz); 2.45 (s, 3H), 4.25 (q, 2H, J¼7.1 Hz); 7.45e7.50
3
2
130.6 (t, JCF¼2.5 Hz); 131.7; 132.5 (t, JCF¼26.0 Hz); 136.6 (t,
(m, 2H); 7.57e7.60 (m, 2H). 13C NMR (CDCl3, 100 MHz)
d, ppm: 11.4;
2JCF¼28.7 Hz); 138.6; 139.3; 142.1 (t, JCF¼2.6 Hz); 166.8. 19F NMR
13.9; 61.5; 111.2 (t, JCF¼1.4 Hz); 114.8 (t, JCF¼246.0 Hz); 125.6 (t,
3 2
4
3
1
(CDCl3, 376 MHz)
d,
ppm: ꢁ83.87 (s). HRMS calcd for
5JCF¼2.3 Hz); 127.2 (t, JCF¼5.5 Hz); 131.8; 133.0 (t, JCF¼26.9 Hz);
158.8 (t, 4JCF¼1.2 Hz); 160.8 (t, 4JCF¼0.7 Hz); 166.3 (t, 2JCF¼36.4 Hz).
C19H17O2F279BrNa: [MþNa]þ: m/z 411.0278. Found: m/z 417.0280
(1 ppm). Compound 17b: White crystals (5 mg, 9% yield). Mp:
63e65 ꢂC. Rf¼0.66 (Et2O/pentane, 20/80).1H NMR (CDCl3, 500 MHz)
19F NMR (CDCl3, 282 MHz)
d
, ppm: ꢁ92.27 (s). 19b: Rf¼0.42 (Et2O/
pentane, 10/90). 1H NMR (CDCl3, 400 MHz)
d, ppm: 1.27 (t, 3H,
d
, ppm: 2.29 (s, 3H); 2.31 (s, 3H); 3.55 (s, 3H); 5.78 (d,1H, J¼12.0 Hz);
J¼7.1 Hz); 2.40 (t, 3H, J¼1.9 Hz); 4.29 (q, 2H, J¼7.1 Hz); 7.41e7.43 (m,
7.04 (d, 1H, J¼12.0 Hz); 7.08 (s, 1H); 7.29e7.33 (m, 2H); 7.36 (s, 1H);
2H); 7.54e7.58 (m, 2H). 13C NMR (CDCl31, 100 MHz)
d, ppm: 11.6 (t,
7.47e7.50 (m, 2H). 13C NMR (CDCl3, 125 MHz)
d
, ppm: 19.5; 19.7;
4JCF¼3.1 Hz); 13.7; 62.7; 117.3 (t, JCF¼240.2 Hz); 119.1 (t,
51.1; 120.5; 120.7 (t, 1JCF¼241.8 Hz); 124.4 (t, 5JCF¼2.3 Hz); 127.3 (t,
2JCF¼34.3 Hz); 125.1 (t, JCF¼2.4 Hz); 127.1 (t, JCF¼5.4 Hz); 131.8;
5
3
3
2
3JCF¼7.5 Hz); 128.1 (t, JCF¼5.0 Hz); 130.8 (t, JCF¼25.2 Hz); 131.4;
135.0 (t, 2JCF¼27.9 Hz); 156.1 (t, 3JCF¼1.2 Hz); 158.0 (t, 3JCF¼4.8 Hz);
131.5; 132.0 (t, 3JCF¼3.0 Hz); 136.5 (t, 2JCF¼28.5 Hz); 136.7; 138.4 (t,
160.0 (t, 4JCF¼0.9 Hz). 19F NMR (CDCl3, 282 MHz)
, ppm: ꢁ83.89 (s).
d
4JCF¼1.4 Hz); 143.0; 165.7.19F NMR (CDCl3, 376 MHz)
d, ppm: ꢁ86.03
HRMS (19aþ19b) (ESI) calcd for C14H12NO3F279BrNa: [MþNa]þ: m/z
(s). HRMS (ESI) calcd for C19H17O2F279BrNa: [MþNa]þ: m/z 411.0278.
381.9866. Found: m/z 381.9868 (0 ppm).
Found: m/z 417.0276 (0 ppm).
Acknowledgements
4.18. 3-Benzyl-5-[(4-bromophenyl)-difluoromethyl]-3H-
[1,2,3]triazole-4-carboxylicacid ethyl ester 18a and 1-benzyl-
5-[(4-bromo-phenyl)-difluoromethyl]-1H-[1,2,3]triazole-4-
carboxylicacid ethyl ester 18b
We thank CNRS and MESR for financial support. We thank
CRMPO (Rennes) for the mass spectral analyses. We thank Drs. P.
Van de Weghe and M. Capet for very fruitful discussions.
The difluoro-propargylicester5 (195 mg, 0.64 mmol,1 equiv) and
benzyl azide (0.12 mL, 1.5 equiv) were stirred, neat, at 60 ꢂC for 6 h.
The adducts 18a and 18b, obtained in a 1/2 ratio by NMR analysis,
were separated by chromatography on silica gel (251 mg, 90% com-
bined yield). Compound 18a (83 mg, 30% yield) was obtained as
white crystals. Mp: 50e52 ꢂC. Rf¼0.41 (Et2O/pentane, 1/9). 1H NMR
References and notes
1. For a very interesting recent literature coverage on corresponding molecules
€
see: Jung, N.; Brase, S. Eur. J. Org. Chem. 2009, 4494e4502 and references cited
therein.
2. For a short selection of representative examples see: Fenoprofen (NSAID),
Triclosan (antibacterial-antifungal); Levothyroxine (hypothyroidism); Bumeta-
mide (diuretic); Deltamethrin (insecticide); Quizalofop-ethyl (herbicide).
3. For a short selection of representative examples see: Ketoprofen (NSAID);
Tolcapone (Parkinson); Fenofibrate (hypolipidaemic); Flubendazole (anthel-
mintics); Amiodarone (antiarrhythmic, cardiovascular system); Enoximone
(cardiotonic).
4. (a) Ojima, I., McCarthy, J. R., Welch, J. T. Biomedical Frontiers in Fluorine
Chemistry; ACS Symposium Series 639: Washington, DC, 1996. (b) Welch, J. T.;
Eswarakrishnan, S. Fluorine in Bioorganic Chemistry; Wiley Interscience: New
York, NY, 1991; (c) Welch, J. T. Tetrahedron 1987, 43, 3123e3197; (d) Isanbor, C.;
O’Hagan, D. J. Fluorine Chem. 2006, 127, 303e319; (e) Begue, J.-P.; Bonnet-Del-
pon, D. J. Fluorine Chem. 2006, 127, 992e1012; (f) Kirk, K. L. J. Fluorine Chem.
2006, 127, 1013e1029 and references cited therein.
5. Kitazume, T.; Kamazaki, T. Experimental Methods in Organic Fluorine Chemistry;
Gordon and Breach Science: Tokyo, 1998.
(CDCl3, 300 MHz)
d, ppm: 1.22 (t, 3H, J¼7.1 Hz); 4.27 (q, 2H, J¼7.1 Hz);
5.87(s, 2H); 7.28e7.36 (m, 5H); 7.44e7.46 (m, 2H); 7.56e7.59(m, 2H).
13C NMR (CDCl3, 75 MHz)
d, ppm: 13.7, 54.1; 62.6; 116.3 (t,
5
3
1JCF¼240.9 Hz); 124.8 (t, JCF¼2.3 Hz); 126.4; 127.6 (t, JCF¼5.6 Hz);
2
128.0; 128.6; 128.8; 131.5; 134.2; 134.9 (t, JCF¼27.1 Hz); 145.4 (t,
2JCF¼34.4 Hz); 157.7. 19F NMR (CDCl3, 282 MHz)
, ppm: ꢁ87.72 (s).
d
HRMS (ESI) calcd for C19H16N3O2F279BrNa: [MþNa]þ: m/z 458.0292.
Found: m/z 458.0288 (1 ppm). Compound 18b (168 mg, 60% yield)
was obtained as white crystals. Mp: 86e88 ꢂC. Rf¼0.40 (Et2O/pen-
ꢀ
ꢀ
tane, 2/8). 1H NMR (CDCl3, 300 MHz)
d, ppm: 1.26 (t, 3H, J¼7.1 Hz);
4.27 (q, 2H, J¼7.1 Hz); 5.76 (s, 2H); 7.01e7.05 (m, 2H); 7.12e7.15 (m,
2H); 7.22e7.31 (m, 3H); 7.35e7.39 (m, 2H). 13C NMR (CDCl3, 75 MHz)
6. Chang, Y.; Terawi, A.; Adi, A.-I.; Bae, C. Tetrahedron 2008, 64, 9837e9842 and
references cited therein.
d
, ppm: 13.9; 54.9 (t, 3JCF¼4.5 Hz); 61.8,116.7 (t,1JCF¼242.7 Hz); 125.5
7. For reviews on the chemistry of propargylic fluorides see: (a) Prakesch, M.;
5
3
ꢀ
ꢀ
(t, JCF¼2.5 Hz); 127.1 (t, JCF¼5.0 Hz); 127.7; 128.7; 128.8; 131.6;
Gree, D.; Gree, R. Acc. Chem. Res. 2002, 35, 175e181; (b) Pacheco, M. C.; Purser,
S.; Gouverneur, V. Chem. Rev. 2008, 108, 1943e1981 and references cited
therein.
2
2
133.1 (t, JCF¼26.9 Hz); 133.8, 134.0 (t, JCF¼34.7 Hz); 139.3 (t,
3JCF¼2.0 Hz); 159.6. 19F NMR (CDCl3, 282 MHz)
, ppm: ꢁ83.185 (s).
d
ꢀ
ꢀ
8. (a) Kerouredan, E.; Prakesch, M.; Gree, D.; Gree, R. Lett. Org. Chem. 2004, 1,
78e80; (b) Pujari, S. A.; Kaliappan, K. P.; Valleix, A.; Gree, D.; Gree, R. Synlett
2008, 2503e2507.
9. Midland, M. M.; Tramontano, A.; Cable, J. R. J. Org. Chem. 1980, 45, 28e29.
10. For a rationalization of the higher reactivity of propargylic systems in nucleo-
philic fluorination see: Prakesch, M.; Kerouredan, E.; Gree, D.; Gree, R.; De
Chancie, J.; Houk, K. N. J. Fluorine Chem. 2004, 125, 537e541.
11. Danishefsky, S. J.; Kitahara, T. J. Am. Chem. Soc. 1974, 96, 7807e7808.
12. Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457e2483.
13. Heck, R. F.; Nolley, J. P. J. Org. Chem. 1972, 37, 2320e2322.
HRMS (ESI) calcd for C19H16N3O2F279BrNa: [MþNa]þ: m/z 458.0292.
ꢀ
ꢀ
Found: m/z 458.0293 (0 ppm).
4.19. 5-[(4-Bromo-phenyl)-difluoro-methyl]-3-methyl-
isoxazole-4-carboxylic acid ethyl ester (19a) and 4-[(4-bromo-
phenyl)-difluoro-methyl]-3-methyl-isoxazole-5-carboxylic
acid ethyl ester (19b)
ꢀ
ꢀ
14. Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508e524.
15. For some previous examples of Pd-catalyzed coupling reactions on heterocycles
A solution of fluoro-alkyne 5 (100 mg, 0.33 mmol), C2H5NO2
ꢀ
ꢀ
with fluorinated side chains see: Blayo, A.-L.; Le Meur, S.; Gree, D.; Gree, R. Adv.
Synth. Catal. 2008, 350, 471e476 and references cited therein.
16. Mukaiyama, T.; Hishino, T. J. Am. Chem. Soc. 1960, 82, 5339e5342.
(70
mL, 3 equiv), PhNCO (110 mL, 3 equiv) and three drops of Et3N in
toluene (5 mL) was stirred, at 50 ꢂC during 3 h. The reaction mixture